New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

To lead the integration and growth of the SPECT business, SHINE has named Michael Rossi as CEO of SHINE SPECT USA, LLC.

When Vladimir Putin put his country's nuclear forces on "special" alert shortly after invading Ukraine, he effectively raised ...

Routine reactor emissions pose no meaningful health risk to the US workers and population, a health physicist and a nuclear ...

CNNC and Suzhou launch China’s first nuclear medicine demonstration base, advancing clinical application, innovation, and ...

As global challenges intensify, nuclear technology is emerging as a practical solution across multiple sectors, offering ...

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

Isotek Systems, in partnership with TerraPower Isotopes, co-created by Bill Gates, are “producing cancer treatment material ...

China National Nuclear Corporation (CNNC) held the Conference on Medical Transformation and Clinical Application of Nuclear ...

Starting in the first quarter of 2026, Rwanda is set to become a producer of radionuclides, a key chemical for nuclear medicine.

About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...